Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AVR NASDAQ:DRTS NASDAQ:INMD NASDAQ:TMCI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAVRAnteris Technologies Global$9.15-1.7%$7.23$2.85▼$10.14$906.26M1.781.34 million shs691,708 shsDRTSAlpha Tau Medical$9.85+1.8%$8.85$2.85▼$11.62$874.35M1.191.04 million shs857,402 shsINMDInMode$13.45-0.3%$13.92$12.72▼$16.74$854.71M1.94812,057 shs448,432 shsTMCITreace Medical Concepts$4.06+3.8%$2.47$1.17▼$7.78$253.65M1.4613,265 shs1.00 million shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAVRAnteris Technologies Global-1.72%-5.08%+40.12%+47.82%+78.71%DRTSAlpha Tau Medical+1.76%+5.35%+2.18%+37.38%+220.85%INMDInMode-0.30%-0.66%-4.20%-0.66%-5.81%TMCITreace Medical Concepts+3.84%+15.67%+60.47%+178.08%-34.20%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAVRAnteris Technologies Global$9.15-1.7%$7.23$2.85▼$10.14$906.26M1.781.34 million shs691,708 shsDRTSAlpha Tau Medical$9.85+1.8%$8.85$2.85▼$11.62$874.35M1.191.04 million shs857,402 shsINMDInMode$13.45-0.3%$13.92$12.72▼$16.74$854.71M1.94812,057 shs448,432 shsTMCITreace Medical Concepts$4.06+3.8%$2.47$1.17▼$7.78$253.65M1.4613,265 shs1.00 million shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAVRAnteris Technologies Global-1.72%-5.08%+40.12%+47.82%+78.71%DRTSAlpha Tau Medical+1.76%+5.35%+2.18%+37.38%+220.85%INMDInMode-0.30%-0.66%-4.20%-0.66%-5.81%TMCITreace Medical Concepts+3.84%+15.67%+60.47%+178.08%-34.20%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAVRAnteris Technologies Global 2.60Moderate Buy$16.0074.86% UpsideDRTSAlpha Tau Medical 2.43Hold$12.6027.92% UpsideINMDInMode 2.00Hold$16.0018.96% UpsideTMCITreace Medical Concepts 1.86Reduce$4.7717.49% UpsideCurrent Analyst Ratings BreakdownLatest TMCI, AVR, DRTS, and INMD Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/4/2026DRTSAlpha Tau Medical BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$15.00 ➝ $17.006/2/2026DRTSAlpha Tau Medical HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$15.005/29/2026AVRAnteris Technologies Global Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)5/28/2026DRTSAlpha Tau Medical BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOverweight$15.005/28/2026DRTSAlpha Tau Medical BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOverweight$15.005/20/2026DRTSAlpha Tau Medical HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$15.005/19/2026DRTSAlpha Tau Medical Piper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$5.00 ➝ $8.005/15/2026AVRAnteris Technologies Global BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$17.00 ➝ $18.005/12/2026DRTSAlpha Tau Medical LADENBURG THALM/SH SHSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$12.00 ➝ $14.005/12/2026DRTSAlpha Tau Medical HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$12.00 ➝ $15.005/7/2026INMDInMode BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetOverweight$21.00 ➝ $19.00(Data available from 6/12/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAVRAnteris Technologies Global$1.91M466.31N/AN/A($0.01) per share-915.00DRTSAlpha Tau MedicalN/AN/AN/AN/A$0.88 per shareN/AINMDInMode$370.49M2.30$1.49 per share9.04$10.78 per share1.25TMCITreace Medical Concepts$212.69M1.24N/AN/A$1.37 per share2.96Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAVRAnteris Technologies Global-$94.14M-$2.23N/AN/AN/A-5,148.78%-124.76%-101.21%8/10/2026 (Estimated)DRTSAlpha Tau Medical-$42.63M-$0.67N/AN/AN/AN/A-73.23%-52.90%8/10/2026 (Estimated)INMDInMode$93.83M$1.369.89N/AN/A23.27%13.47%11.95%7/23/2026 (Estimated)TMCITreace Medical Concepts-$59M-$0.97N/AN/AN/A-29.44%-67.04%-30.28%8/6/2026 (Estimated)Latest TMCI, AVR, DRTS, and INMD EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/18/2026Q1 2026DRTSAlpha Tau Medical-$0.13-$0.26-$0.13-$0.26$0.05 millionN/A5/12/2026Q1 2026AVRAnteris Technologies Global-$0.2708-$0.28-$0.0092-$0.28$0.77 million$0.49 million5/8/2026Q1 2026TMCITreace Medical Concepts-$0.31-$0.28+$0.03-$0.28$45.96 million$47.20 million5/6/2026Q1 2026INMDInMode$0.2978$0.25-$0.0478$0.18$79.84 million$82.02 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthAVRAnteris Technologies GlobalN/AN/AN/AN/AN/ADRTSAlpha Tau MedicalN/AN/AN/AN/AN/AINMDInModeN/AN/AN/AN/AN/ATMCITreace Medical ConceptsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAVRAnteris Technologies GlobalN/A20.9320.93DRTSAlpha Tau Medical0.097.797.79INMDInModeN/A8.807.88TMCITreace Medical Concepts0.723.582.53Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAVRAnteris Technologies GlobalN/ADRTSAlpha Tau Medical2.65%INMDInMode68.04%TMCITreace Medical Concepts84.08%Insider OwnershipCompanyInsider OwnershipAVRAnteris Technologies Global4.50%DRTSAlpha Tau Medical39.50%INMDInMode6.92%TMCITreace Medical Concepts23.42%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAVRAnteris Technologies Global13897.34 million92.96 millionN/ADRTSAlpha Tau Medical8090.33 million54.65 millionNo DataINMDInMode48063.36 million58.98 millionOptionableTMCITreace Medical Concepts25064.87 million49.68 millionOptionableTMCI, AVR, INMD, and DRTS HeadlinesRecent News About These CompaniesTreace Medical Concepts (NASDAQ:TMCI) CEO John Treace Buys 22,887 SharesJune 12 at 7:18 AM | insidertrades.comTreace to Present at the Sidoti Small Cap ConferenceJune 11 at 4:05 PM | globenewswire.comTreace Medical Concepts (NASDAQ:TMCI) CEO John Treace Acquires 50,000 SharesJune 2, 2026 | insidertrades.comTreace Medical Concepts Balances Growth With Earnings StrainJune 1, 2026 | tipranks.comJohn Treace Purchases 4,508 Shares of Treace Medical Concepts (NASDAQ:TMCI) StockMay 29, 2026 | insidertrades.comWilliam Blair Investment Management LLC Sells 2,488,883 Shares of Treace Medical Concepts, Inc. $TMCIMay 27, 2026 | marketbeat.comTreace Medical Shareholders Back Directors, Pay and AuditorMay 20, 2026 | tipranks.comTreace Medical Concepts, Inc.May 15, 2026 | edition.cnn.comTreace Medical Concepts (NASDAQ:TMCI) CEO John Treace Buys 43,000 SharesMay 15, 2026 | insidertrades.comTreace Medical Concepts, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their LossesMay 12, 2026 | globenewswire.comTreace Medical Concepts Inc (TMCI) Q1 2026 Earnings Call Highlights: Navigating Revenue ...May 9, 2026 | finance.yahoo.comTreace Medical Concepts: Q1 Earnings SnapshotMay 8, 2026 | myjournalcourier.comMTreace Medical Concepts (TMCI) Reports Q1 Loss, Beats Revenue EstimatesMay 8, 2026 | zacks.comTreace Medical Concepts Reports First Quarter 2026 Financial ResultsMay 8, 2026 | globenewswire.comTreace Medical Concepts Inc (TMCI) Q1 2026 Earnings Report Preview: What To ExpectMay 7, 2026 | finance.yahoo.comHow The Treace Medical Concepts (TMCI) Story Is Shifting With Mixed Analyst ExpectationsMay 3, 2026 | finance.yahoo.comTreace Medical Concepts, Inc. to Release First Quarter 2026 Financial Results and Host Conference CallApril 24, 2026 | quiverquant.comQTreace to Report First Quarter 2026 Financial Results on May 8, 2026April 24, 2026 | globenewswire.comHow The Treace Medical Concepts (TMCI) Narrative Is Shifting With New Targets And Product PlansApril 18, 2026 | finance.yahoo.comTreace Medical Concepts Announces Leadership Transition and OutlookApril 11, 2026 | theglobeandmail.comTreace Medical Concepts (TMCI) price target increased by 12.28% to 4.08April 10, 2026 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTMCI, AVR, INMD, and DRTS Company DescriptionsAnteris Technologies Global NASDAQ:AVR$9.15 -0.16 (-1.72%) Closing price 06/12/2026 04:00 PM EasternExtended Trading$9.54 +0.39 (+4.26%) As of 06/12/2026 05:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.Alpha Tau Medical NASDAQ:DRTS$9.85 +0.17 (+1.76%) Closing price 06/12/2026 04:00 PM EasternExtended Trading$9.85 0.00 (0.00%) As of 06/12/2026 06:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.InMode NASDAQ:INMD$13.45 -0.04 (-0.30%) Closing price 06/12/2026 04:00 PM EasternExtended Trading$13.42 -0.04 (-0.26%) As of 06/12/2026 07:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.Treace Medical Concepts NASDAQ:TMCI$4.06 +0.15 (+3.84%) Closing price 06/12/2026 04:00 PM EasternExtended Trading$4.12 +0.06 (+1.35%) As of 06/12/2026 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas SpaceX Rings the Bell and Shatters Every Record Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story? ERock IPO: A $1.3B Power Play Solution Boeing’s Unseen Rebound: Why the Headlines Are Wrong Why Oracle's 10% Drop May Be Telling the Wrong Story Spotify's "North Star" Outlook Was Music to Investors Ears DraftKings Hits the Jackpot With Super App Pivot Cracker Barrel Surges 23% as Earnings Beat Signals Turnaround Progress Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
